SCHEMBL16718784

SCHEMBL16718784

N#Cc1ccc(C23CCC(NC(=O)c4cnn5c4CN(C(N)=O)CC5)(CC2)CC3)cc1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CSNK1D P48730 4/20 0.36
▸ CSNK1E P49674 4/20 0.36
▸ TNF P01375 6/20 0.35
▸ IRAK4 Q9NWZ3 6/20 0.35
▸ CYP11B1 P15538 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ JAK1 P23458 4/20 0.31
▸ JAK3 P52333 3/20 0.31
▸ JAK2 O60674 2/20 0.31
▸ TYK2 P29597 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ AR P10275 1/20 0.31
▸ CDK1 P06493 1/20 0.31
▸ MYT1 Q01538 1/20 0.31
▸ POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16700166 0.88 CASR (0.36) CSNK1DCSNK1E
SCHEMBL16699389 0.80 CASR (0.31) CSNK1DCSNK1E
SCHEMBL16700251 0.77 DRD3 (0.31) —
SCHEMBL17527367 0.76 CSNK1E (0.51) CSNK1DCSNK1E
SCHEMBL16718783 0.74 CSNK1E (0.49) CSNK1DCSNK1E
SCHEMBL16698729 0.74 CD38 (0.31) —
SCHEMBL28611830 0.68 CSNK1D (0.36) CSNK1DCSNK1ECDK1MYT1
SCHEMBL16699410 0.68 CSNK1E (0.40) CSNK1DCSNK1EJAK3
SCHEMBL16701047 0.68 CSNK1E (0.58) CSNK1DCSNK1E
SCHEMBL16711325 0.68 CSNK1E (0.57) CSNK1DCSNK1E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3068785-A1 SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS Bristol-Myers Squibb Company (US) 2016-09-21 — — EP disclosed
WO-2015073763-A1 SUBSTITUTED 4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS CASEIN KINASE 1 D/E INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-05-21 — — WO disclosed
Send feedback